Study on the Effect of Rosuvastatin Treatment on the Prevention of Thrombosis in Patients With Previous Thrombosis
Status:
Withdrawn
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
This study evaluates whether treatment with rosuvastatin on top of standard anti-coagulant
treatment will decrease the risk of recurrent venous thromboembolism and arterial
thromboembolic events in patients with previous deep vein thrombosis or pulmonary embolism.